These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1281386)
21. Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6. Abrahams NA; Bostwick DG; Ormsby AH; Qian J; Brainard JA Am J Clin Pathol; 2003 Sep; 120(3):368-76. PubMed ID: 14502799 [TBL] [Abstract][Full Text] [Related]
22. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Cheville JC; Reznicek MJ; Bostwick DG Am J Clin Pathol; 1997 Dec; 108(6):633-40. PubMed ID: 9384444 [TBL] [Abstract][Full Text] [Related]
23. Adenosis of the prostate. Histologic features in transurethral resection specimens. Gaudin PB; Epstein JI Am J Surg Pathol; 1994 Sep; 18(9):863-70. PubMed ID: 7520673 [TBL] [Abstract][Full Text] [Related]
24. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis of prostate carcinoma on biopsy specimens improved by basal-cell-specific anti-cytokeratin antibody (34 beta E12). Freibauer C Wien Klin Wochenschr; 1998 Sep; 110(17):608-11. PubMed ID: 9816630 [TBL] [Abstract][Full Text] [Related]
26. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
27. Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach. Luebke AM; Schlomm T; Gunawan B; Bonkhoff H; Füzesi L; Erbersdobler A Virchows Arch; 2005 Mar; 446(3):338-41. PubMed ID: 15726402 [TBL] [Abstract][Full Text] [Related]
28. The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland. Jones EC; Young RH Am J Clin Pathol; 1994 Jan; 101(1):48-64. PubMed ID: 7506479 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland. O'Malley FP; Grignon DJ; Shum DT Virchows Arch A Pathol Anat Histopathol; 1990; 417(3):191-6. PubMed ID: 1696762 [TBL] [Abstract][Full Text] [Related]
30. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma. Helpap B; Riede C Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355 [TBL] [Abstract][Full Text] [Related]
31. Prostate pathology case study seminar. Montironi R; Alexander E; Bostwick DG Virchows Arch; 1997 Jan; 430(1):83-94. PubMed ID: 9037320 [TBL] [Abstract][Full Text] [Related]
32. [Prostatic squamous cell cancer and its differential diagnostic contrast with squamous cell metaplasia]. Samsonov VA Arkh Patol; 1984; 46(8):23-9. PubMed ID: 6208883 [TBL] [Abstract][Full Text] [Related]
34. [Sclerosing adenosis of the prostate. Carcinoma simulation]. Meister P Pathologe; 1996 Mar; 17(2):157-62. PubMed ID: 8650147 [TBL] [Abstract][Full Text] [Related]
35. [Relations between atypical hyperplasia, dysplasia and prostatic cancer and the significance of its appearance for the clinician]. Hoffmann L; Putzke HP; Günther I; Rodewald P; Erdmann T Z Urol Nephrol; 1987 Oct; 80(10):561-9. PubMed ID: 2448971 [TBL] [Abstract][Full Text] [Related]
36. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Parsons JK; Gage WR; Nelson WG; De Marzo AM Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556 [TBL] [Abstract][Full Text] [Related]
37. Atypical adenomatous hyperplasia (adenosis) of the prostate. Humphrey PA J Urol; 2012 Dec; 188(6):2371-2. PubMed ID: 23000851 [No Abstract] [Full Text] [Related]
38. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. Coogan CL; Bostwick DG; Bloom KJ; Gould VE Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317 [TBL] [Abstract][Full Text] [Related]
39. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate]. Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979 [TBL] [Abstract][Full Text] [Related]
40. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Maygarden SJ; Strom S; Ware JL Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]